Patients with Cystic Fibrosis have malabsorption of the fat-soluable vitamins ADEK. In your professional experience, have you seen a direct correlation with INR variation and/or warfarin dosing requirements in cystic fibrosis patients with co-existing coagulopathies/thrombophilias?